v3.26.1
Supplemental Financial Information - Accounts Payable and Accrued Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Other Balance Sheet Details [Abstract]    
Sales rebates and reserves $ 292.1 $ 226.0
Current income taxes payable 114.6 68.0
Accrued development costs 93.5 101.3
Accrued employee related costs 123.2 128.8
Current branded prescription drug fee 42.9 45.3
Accounts payable and other accrued liabilities 142.0 104.9
Total accounts payable and accrued liabilities $ 808.3 $ 674.3